文献速递肿瘤 PET/CT

比较[99mTc]Tc-替尔曼诺塞普与[99mTc]Tc-硫胶体和[99mTc]Tc-白蛋白胶体在头颈部皮肤恶性肿瘤患者前哨淋巴结检测中的应用

Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-10-28

该研究回顾性分析了2012至2021年间62例头颈部皮肤恶性肿瘤患者,比较[99mTc]Tc-替尔曼诺塞普(TcTM)、[99mTc]Tc-硫胶体(TcSC)和[99mTc]Tc-白蛋白胶体(TcAC)在前哨淋巴结成像(SLN-I)和切除(SLN-E)中的表现。结果显示TcTM在SLN-I定位率上与TcSC和TcAC相似,在前头部原发灶的SLN-I定位程度(淋巴结数量)上高于TcSC和TcAC,但SLN-E再定位率和比值三组相似。作者结论认为,基于比较三种不同示踪剂在三个不同患者组中的有限研究设计,TcTM总体表现与TcSC和TcAC相当。

要点

  • TcTM组前头部原发灶SLN-I定位程度为3.2,高于TcSC组的2.3(p=0.034)和TcAC组的2.0(p=0.038)。
  • TcTM组后头部原发灶SLN-I定位程度与TcSC组(1.8 vs 2.2,p=0.506)和TcAC组(1.8 vs 2.7,p=0.329)相似。
  • 三组SLN-E再定位率和比值均相似。

核心结论

  • 基于比较三种不同示踪剂在三个不同患者组中的有限研究设计,TcTM总体表现与TcSC和TcAC相当。

研究设计与样本

  • 回顾性分析2012至2021年间62例头颈部皮肤恶性肿瘤患者,分别注射TcTM、TcSC或TcAC后行SLN-I和SLN-E。
  • SLN-I采用平面淋巴显像和SPECT/CT,SLN-E使用伽马探头。
  • 比较TcTM、TcSC和TcAC组的SLN-I定位率(有SLN的患者)和程度(SLN数量)以及SLN-E再定位率(有SLN的患者)和比值(SLN-E中SLN数量/SLN-I中SLN数量)。

主要发现

  • TcTM组前头部原发灶SLN-I定位率为84.6%,与TcSC组的72.4%相比p=0.680,与TcAC组的75.0%相比p=1.000。
  • TcTM组后头部原发灶SLN-I定位率与TcSC组和TcAC组均为100.0%。
  • TcTM组前头部原发灶SLN-I定位程度为3.2,高于TcSC组的2.3(p=0.034)和TcAC组的2.0(p=0.038)。
  • TcTM组后头部原发灶SLN-I定位程度为1.8,与TcSC组的2.2(p=0.506)和TcAC组的2.7(p=0.329)相似。
  • 三组SLN-E再定位率和比值均相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述研究设计有限,比较了三种不同示踪剂在三个不同患者组中的表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Sentinel lymph node (SLN) biopsy is a staging procedure in the management of cutaneous malignancies of the head. The ideal radiopharmaceutical is controversial. This study aimed to compare [99mTc]Tc-tilmanocept (TcTM) with [99mTc]Tc-sulphur colloid (TcSC) and [99mTc]Tc-albumin colloid (TcAC) for SLN detection in the head and neck region. METHODS: Data from 62 patients with cutaneous malignancies of the head who were injected with TcTM, TcSC, or TcAC before SLN imaging (SLN-I) and SLN excision (SLN-E) between 2012 and 2021 were retrospectively analysed. SLN-I was performed using planar lymphoscintigraphy and SPECT/CT, and a gamma probe was used for SLN-E. The SLN-I localisation rate (patients with SLNs) and degree (SLN number) and SLN-E relocalisation rate (patients with SLNs) and ratio (SLN number in SLN-E/SLN number in SLN-I) were compared between TcTM, TcSC, and TcAC. RESULTS: TcTM showed similar SLN-I localisation rates for primaries in the anterior and posterior head region compared with TcSC (84.6% vs. 72.4%, p=0.680; both 100.0%) and TcAC (84.6% vs. 75.0%, p=1.000; both 100.0%). The SLN-I localisation degree for TcTM was higher for primaries in the anterior head region and similar for primaries in the posterior head region compared with TcSC (3.2 vs. 2.3, p=0.034; and 1.8 vs. 2.2, p=0.506) and TcAC (3.2 vs. 2.0, p=0.038; and 1.8 vs. 2.7, p=0.329). The SLN-E relocalisation rates and ratios were similar for all. CONCLUSION: On the basis of a limited study design that compared three different tracers in three different patient groups, TcTM showed comparable overall performance to TcSC and TcAC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ooms M, von Mallek D, Kaiser HJ, et al. Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head. Eur J Nucl Med Mol Imaging. 2022. PMID: 36305908. doi:10.1007/s00259-022-06017-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。